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Abstract
Background: Genetic heterozygosity is increasingly being shown to be a key predictor of fitness
in natural populations, both through inbreeding depression, inbred individuals having low
heterozygosity, and also through chance linkage between a marker and a gene under balancing
selection. One important component of fitness that is often highlighted is resistance to parasites
and other pathogens. However, the significance of equivalent loci in human populations remains
unclear. Consequently, we performed a case-control study of fatal invasive bacterial disease in
Kenyan children using a genome-wide screen with microsatellite markers.
Methods: 148 cases, comprising children aged <13 years who died of invasive bacterial disease,
(variously, bacteraemia, bacterial meningitis or neonatal sepsis) and 137 age-matched, healthy
children were sampled in a prospective study conducted at Kilifi District Hospital, Kenya. Samples
were genotyped for 134 microsatellite markers using the ABI LD20 marker set and analysed for an
association between homozygosity and mortality.
Results: At five markers homozygosity was strongly associated with mortality (odds ratio range
4.7 – 12.2) with evidence of interactions between some markers. Mortality was associated with
different non-overlapping marker groups in Gram positive and Gram negative bacterial disease.
Homozygosity at susceptibility markers was common (prevalence 19–49%) and, with the large
effect sizes, this suggests that bacterial disease mortality may be strongly genetically determined.
Conclusion: Balanced polymorphisms appear to be more widespread in humans than previously
appreciated and play a critical role in modulating susceptibility to infectious disease. The effect sizes
we report, coupled with the stochasticity of exposure to pathogens suggests that infection and
mortality are far from random due to a strong genetic basis.
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Background
Many recent studies of natural populations report a corre-
lation between genetic heterozygosity (heterozygosity-fit-
ness correlation, HFC), measured at a small number (of
the order of 10) of presumed neutral markers, and fitness
[1,2]. Fitness measures range widely from survival [3] and
reproductive success [4-6] to indirect traits such as song
complexity [7] and territory size [8] in birds. Some of the
most frequently reported traits relate to immune function
[9] and susceptibility to micro- [10] and macroparasites
[11-13]. Such studies raise obvious questions, both about
the mechanism responsible, and whether similar patterns
may affect humans.
Two primary mechanisms have been suggested to explain
HFCs [14,15]. First, relatively homozygous individuals
may be more susceptible to infection because they are
inbred. Here, average heterozygosity at the panel of mark-
ers being genotyped estimates genome-wide heterozygos-
ity, which in turn estimates the inbreeding coefficient, F.
However, several theoretical treatments have come to the
conclusion that such a mechanism is unlikely to operate
in most real populations [16-18]. The problem is that ran-
dom mating generates extremely few individuals with suf-
ficiently high F for their heterozygosity to stand out when
measured at tens or even hundreds of markers, unless the
population is very small or highly polygynous. Humans
may offer a further exception in cultures where cousin
marriages are actively encouraged [19], potentially
increasing the rate of heritable diseases [20,21].
The second mechanism that may generate HFCs involves
chance linkage between one or more of the markers and a
gene(s) experiencing balancing selection. Balancing selec-
tion has often been thought to be rather rare, particularly
in humans [22] where the classical example is sickle cell
anemia [23] remains one of very few examples. Moreover,
while some argue that polymorphism at immune func-
tion genes is maintained by overdominant balancing
selection [24], there is evidence that this is unlikely to be
effective at maintaining more than two alleles [25-27].
Regardless of theory, a number of recent HFC studies
report convincing associations between heterozygosity at
one particular locus and the measured trait [13,28-31].
Over the last five to ten years, association studies examin-
ing the genetic basis of human disease have switched over-
whelmingly from microsatellite markers to single
nucleotide polymorphisms (SNPs) [32]. SNPs are much
less polymorphic than microsatellites, a deficiency that is
usually compensated for by the vastly greater number of
markers being genotyped. However, while there are many
advantages to using SNPs for the assessment of local het-
erozygosity, microsatellites offer an arguably more direct
approach that circumvents the need to reconstruct com-
plex haplotypes. To assess the possible importance of
HFCs in humans, we therefore conducted a case-control
study in a population of Kenyan children, using a panel of
microsatellite markers to quantify both local and genome-
wide heterozygosity.
Results
All our samples were drawn from a prospective study in
Kilifi District Hospital and were genotyped for 134 micro-
satellite markers using the ABI LD20 marker set (Applied
Biosystems, USA) [see Additional file 1]. Cases (n = 148)
comprised a consecutive series of children aged <13 years
who died of invasive bacterial disease, (variously, bacter-
aemia, bacterial meningitis or neonatal sepsis, for details
see methods), a major contributor to childhood mortality
in the developing world [33]. Controls comprised 137
randomly selected healthy children matched on age to the
cases. Microsatellite traces were scrutinised carefully to
ensure homozygotes were identified with high accuracy.
For the study of HFCs a number of measures of heterozy-
gosity have been proposed that offer potential benefits
over straight heterozygosity, weighting scores variously by
allele size (mean d2)[3], allele frequencies (internal relat-
edness, IR) [6] and the variability of loci scored (HL) [34].
However, in automated high throughput studies, hetero-
zygosity assessment can sometimes be problematic, par-
ticularly where time for scrutiny of every trace is limited.
Thus, null (non-amplifying) alleles, allele drop-out and,
at some loci, high levels of stutter-bands can all contribute
to a tendency for a minority of loci to carry misleading
genotypes where heterozygotes are called as homozygotes
or vice versa. Issues have also been identified with allele
binning, in some cases causing single alleles to be split
between two length classes [35]. In an attempt to circum-
vent these problems we spent most empirical effort ensur-
ing that heterozygotes and homozygotes were accurately
scored and introduce a variant of the measure Standard-
ised Heterozygosity (SH) [2], designed to be highly con-
servative. SH controls for missing data by expressing
heterozygosity as the ratio of the observed heterozygosity
in an individual relative to the expected value at the mark-
ers genotyped, assuming Hardy-Weinberg equilibrium.
Our measure, Standardised Observed Homozygosity
(SOH), follows the same principle but instead of calculat-
ing the expected homozygosity from the allele frequen-
cies, we used the observed homozygosity at each locus. In
this way, SOH measures the extent to which any given
individual is more or less homozygous relative to the level
expected if all genotypes were randomized among indi-
viduals, negating the requirement for accurate allele fre-
quency estimates and reducing the impact of allele drop
out, null alleles and other possible artefacts.
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We first asked whether SOH varied significantly among
disease categories by conducting a one-way ANOVA. Raw
SOH values exhibit a slightly skewed distribution, but this
is removed by a simple log transformation (Shapiro-Wilk
normality test, W = 0.9941, p = 0.322). Following trans-
formation, SOH revealed highly significant variation
among disease classes (F [5,281] = 6.75, P = 5.89 × 10-6) (Fig-
ure 1). However, when the control class was excluded, the
ANOVA was no longer significant (F  [4,144] = 0.785, P =
0.54), indicating that the main effect is driven by a differ-
ence in heterozygosity between cases and controls rather
than between disease classes. The direction of the devia-
tion is toward greater homozygosity in cases compared
with the controls.
We next asked whether there was evidence of local effects
due to chance linkage between one or more markers and
a gene(s) experiencing balancing selection. To test this
proposition we calculated age-adjusted odds ratios of
mortality at each locus in turn (Figure 2). Most markers
show either a non-significant or borderline (at alpha =
0.05) association between homozygosity and risk of mor-
tality. However, nine markers reveal a strong associations
with experiment wide significance using full Bonferroni
correction (p < 0.00037, see Table 1). This is a highly con-
servative threshold since where multiple markers are
expected, the less stringent false discovery rate approach
can be justified [36]. Although the spacing between mark-
ers is sufficient to ensure they behave as if unlinked, it is
possible that multiple markers contribute to the same risk
through linkage to related genes. Consequently, we then
constructed a multivariable logistic regression model with
mortality as the response and age, sex, locality, SOH and
homozygosity at each of the nine largest-effect markers as
explanatory variables. Sequential removal of terms that
did not contribute significantly (likelihood ratio test, p <
Analysis of variance of standardized observed homozygosity values for cases and controlsFigure 1
Analysis of variance of standardized observed homozygosity values for cases and controls. SOH is the Standardised 
Observed Homozygosity for an individual genotyped for i loci, calculated as:  where Nhom is the number of 
homozygote genotypes in the individual concerned and Hoi is the observed frequency of homozygotes at one of the i loci 
scored in this individual. ***indicates a highly significant test where P < 1 × 10-5. The IBI + malaria group includes individuals 
who had invasive bacterial disease but also malaria parasitaemia so that the contribution of the latter to mortality could not be 
determined with certainty. Sample sizes for the disease classes are as follows: control = 183, bacteraemia = 71, meningitis = 18, 
neonatal sepsis = 26 and IBI + malaria parasitaemia = 34. IBI: invasive bacterial infection. Error bars are ± 1 standard error.
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0.05) yielded a final model containing age, location and
five markers (D12S310, D13S158, D14S275, D16S3103,
D16S423). SOH is dropped as a marginally significant
term (LHR, p~0.07) whether fitted as a continuous varia-
ble or as a factor with five levels. By implication, it seems
that genome-wide effects (inbreeding depression) are
minimal or absent.
Beginning with the final model derived above, we
explored further possible interactions between markers,
and also between each marker and age. Among all possi-
ble pair-wise combinations of markers, two revealed sig-
nificant interactions, both of which were retained in the
model regardless of the order in which they were added
(Table 2, last two columns). No significant interactions
with age were detected. Our data contain approximately
equal numbers of individuals who died from Gram posi-
tive (n = 63), gram negative (n = 79) or both (n = 6) infec-
tions and this allowed us to ask whether our markers
identify genes that impact differently on diseases caused
by bacteria of different classes. We therefore repeated the
logistic regression approach above on each bacterial class
separately, including dual infections in both analyses.
Given the smaller datasets, criteria for initial inclusion in
the model were relaxed to an initial OR significant at p <
0.005. The final models are summarized in Table 2 and
reveal surprising complexity, with susceptibility to gram
positive and gram negative infections associated mostly
with non-overlapping genomic locations. Only marker
D12S310 is significant in all three models. Marker
D9S164 reveals an interaction with age, infants being
more likely to die if homozygous (OR = 1.65) and older
children less (OR = 0.18). Interactions between marker
pairs in the whole dataset suggest that homozygosity at
both markers together confers no greater risk than
homozygosity at either one alone. However, in the gram
negative model the interaction of homozygosity at two
markers, D7S486 and D16S423, indicates a significantly
synergistic risk of mortality (odds ratio 40.7) where
homozygosity at either of the markers alone confers no
risk.
Finally, to assess the magnitude of homozygosity effects
with respect to the population, we calculated the popula-
tion attributable risk fraction (PARF) [37] for each marker
(Table 3). PARFs indicate the proportional reduction in
Odds ratios and 95% confidence intervals for mortality and homozygosity by marker, adjusting for ageFigure 2
Odds ratios and 95% confidence intervals for mortality and homozygosity by marker, adjusting for age. Age-
adjusted odds ratios (with 95% confidence intervals) of mortality at each locus. All markers were tested for significance using a 
chi-squared test based on a simple 2 × 2 contingency table (case/control vs homozygotes/heterozygotes). ORs shown in dark 
blue are non-significant. ORs shown in pale blue are significant at P < 0.05 and ORs shown in pink (n = 9) are significant at P < 
0.00037 (i.e. significant experiment-wide at P < 0.05).
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mortality due to bacterial infection that would result if
homozygosity at the locus could be eliminated. However,
such direct interpretation in our case is problematic for
many reasons, including the fact that the risk is probably
driven by specific alleles whose prevalence differs greatly
from that of homozygotes in general. None the less, the
ORs of the full model indicate that the risks we describe
are sizeable, particularly since the markers provide only
indirect measures of homozygosity at the genes them-
selves. Furthermore, given that the population prevalence
of homozygosity at the relevant markers is high, the pop-
ulation-wide effects of homozygosity are likely to impact
Table 1: Nine microsatellites showing the strongest association between heterozygosity and mortality due to invasive bacterial 
disease.
Marker OR lower 95% CI upper 95% CI chi sq p value
D12S310 2.86 1.68 4.86 15.420 0.000086
D12S352 2.66 1.64 4.31 16.194 0.000057
D13158 2.67 1.66 4.3 16.496 0.000049
D14S261 3.14 1.94 5.09 21.998 0.000003
D14S275 2.59 1.59 4.22 15.034 0.000106
D14S280 3.57 2.05 6.21 21.421 0.000004
D15S1007 2.64 1.63 4.28 16.093 0.000060
D16S423 2.60 1.6 4.21 15.368 0.000088
D16S3103 2.89 1.75 4.77 17.611 0.000027
The table shows odds ratios (OR), adjusted for age in 6 strata and geographical location in 8 strata, of death due to bacterial invasive disease, along 
with lower and upper 95% confidence intervals (CI). Significance was assessed using 2 × 2 contingency table of heterozygote/homozygote vs case/
control, yielding a chi-squared value (chi sq) and its associated P value. All loci comfortably exceed the experiment-wide significance threshold of 
0.00037.
Table 2: Age- and geographic location-adjusted odds ratios for invasive bacterial death with homozygosity at specific microsatellite 
markers in multivariable models restricted to cases of Gram positive sepsis, gram negative sepsis or including all invasive bacterial 
deaths combined.
Gram Negative Gram Positive Combined
Markers Interaction OR 95% CI OR 95%CI OR 95% CI
D7S486 1.02 0.16 – 6.53
D7S486 D16S423 40.7 4.28 – 387
D12S310 14.0 2.70 – 72.7 4.73 1.59–14.1 4.94 2.27 – 10.8
D13S158 6.11 1.45 – 25.8 4.66 1.92 – 11.3
D15S1007 7.28 1.89 – 28.1
D16S423 1.61 0.31 – 8.33 7.65 2.55 – 22.9
D9S164 infants 0.18 0.018 – 1.90
D9S164 children 1.65 0.249 – 10.9
D14S275 3.93 1.35 – 11.4 12.2 4.44 – 33.3
D14S275 D13S158 10.1 3.84 – 26.5
D16S3103 3.70 1.20 – 11.4 7.04 2.56 – 19.4
D16S3103 D16S423 10.2 4.10 – 25.2
The table shows odds ratios, adjusted for age in 6 strata and for geographical location in 8 strata, of death due to all invasive bacterial disease, of 
death due to Gram negative invasive bacterial disease and of death due to Gram positive invasive bacterial disease, for homozygosity at 
microsatellite markers either alone or paired (where interactions were noted with LRT p values < 0.05). Variables excluded, with LRT p values = 
0.05, in addition to sex and SOH, were markers d12s352, d14s261, d14s275, d16s3103 and d18s452 in the gram negative model, markers d13s158, 
d14s261, d14s280 and d16s423 in the gram positive model and markers d12s352, d14s261, d14s280 and d15s1007 in the combined model. 
Variables and interaction terms in the final models all had LRT p values < 0.02.
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very considerable on the total burden of invasive bacterial
disease mortality, with the majority of deaths being genet-
ically determined.
Discussion
Here we conduct what we believe is the first systematic
analysis of the association between heterozygosity and
infectious diseases in humans. Although cases exhibit
generally increased homozygosity relative to controls,
more detailed analysis indicates that this is largely due to
a small subset of markers, each of which contributes a sig-
nificant risk factor when homozygous. We conclude that
heterozygosity at a minimum of five loci contributes ORs
of up to 40, and that the most important loci vary depend-
ing on the type of pathogen.
There is currently a debate as to whether the benefits of
heterozygosity accrue mainly through genome-wide
effects (inbreeding) [38,39] or through individual bal-
anced polymorphisms [13,14]. We found that inbreeding
effects are either small or absent in this population. This
is perhaps not surprising because, in contrast to some
other populations such the Fulani [40] and some Arab
communities [19], consanguineous marriages tend to be
discouraged, with a preference for marriages between
rather than within clans [41]. In contrast, five loci inde-
pendently contribute significant risk factors, lending
strong support to the local effects model. However, it
should be remembered that human populations differ
greatly in their structure and that, in contrast to most ani-
mals populations, some human populations actually
favour consanguineous marriages [19,40,42]. In such
populations a rather different pattern may well emerge.
To find several balanced polymorphisms in a relatively
small study of just 134 markers is surprising, given how
few have been identified previously in humans [22]. Two
factors may contribute to this discrepancy. First, a large
majority of genome scans focus on complex, non-infec-
tious diseases, and these are likely to differ from infectious
diseases mechanistically. Most heritable non-infectious
diseases involve mutant alleles at one or more loci where
function is removed or disrupted, and hence are mostly
recessive. In contrast, the efficacy of immune-function
genes is widely though to benefit from high diversity, a
larger palette of alleles increasing the range of pathogen
types that can be recognised, and therefore these loci tend
naturally towards heterosis. Second, classical association
studies tend to be applied to diseases that are known to
run in families [43,44], and hence susceptibility will tend
to have an appreciable additive component. As such, pat-
terns where heterozygosity is important will tend to be
overlooked because heterozygosity per se tends not to be
heritable. Instead there is a strong focus on searching for
associations between particular alleles and disease
[43,45,46]. It will be interesting to see the extent to which
future studies reveal a much higher prevalence of balanc-
ing selection, thereby supporting results from many non-
human systems.
Our current study is relatively small-scale, with several of
the smaller chromosomes being scored for only three or
four markers. Consequently, there are large tracts of the
genome where further loci could be located with the
potential to contribute even further to genetic susceptibil-
ity, and implying that the five regions we identify are not
the complete set of the loci that could potentially be iden-
tified in a larger study. This is surprising because the loci
we have uncovered exhibit large individual and combined
effect sizes, to the extent that mortality appears highly
non-random. Moreover, it should be remembered that
the overall risk factor combines both genetic susceptibility
and variation in exposure. Unless exposure to pathogens
is highly uniform, the impact of genetic factors will be
even higher than we report and could rise further if our
study has missed further contributory loci.
The effect sizes we report appear much larger than
expected. Across the five loci identified as having highest
impact, population attributable risk fractions (PARFs) all
lie in the range 25–55%. PARFs provide an indication of
the proportion of total risk that can be attributed to each
genetic factor, given the local prevalence of exposure.
Since the calculations assume overlapping effects, these
do not sum to one. None the less, our analysis suggests
that half or more of the observed deaths would probably
Table 3: Population attributable risk fractions (PARF) for homozygosity at five microsatellite markers in a final multivariable model of 
bacterial diseases death.
Microsatellite marker population prevalence of homozygosity OR for bacterial disease death PARF
D12S310 0.187 3.65 0.331
D13S158 0.387 2.04 0.287
D14S275 0.282 4.68 0.509
D16S3103 0.490 3.52 0.553
D16S423 0.418 2.75 0.423
PARFs were calculated using all markers retained in the final multivariable logistic regression model but, for simplicity, without interaction effects. 
For this reason the Odds Ratios quoted here are not identical to those in table 2.
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not have occurred if the individuals concerned had been
heterozygous for these loci, a figure that would surely be
even higher if we had been able to genotype SNPs in the
genes concerned rather than at linked microsatellites.
The idea that pathogens could play a major role in driving
balancing selection at many different locations across the
genome is reinforced by the difference we found between
Gram negative and Gram positive bacteria. Immune
defense mechanisms against Gram positive and Gram
negative pathogens vary significantly [47,48], and while
there may be some degree of overlap in genetic regulation
of immunity to different classes of pathogens, the differ-
ence we find between Gram negative and Gram positive
strains would help to explain why so many different
regions appear to be involved.
Conclusion
We believe our study is the first to apply to humans the
sorts of analysis that commonly reveal single locus heter-
osis maintained by pathogens in natural populations. We
reveal several discrete genomic locations where heterozy-
gosity confers some degree of protection from lethal bac-
terial infection. Together these loci contribute a
substantial risk factor that makes mortality from infection
highly non-random. Our study has obvious implications
for epidemiology and could lead to the development of
simple tests for individuals who are most at risk from
infection. High density SNP mapping is under way in
order to identify relevant genes.
Methods
Meningitis is defined by a positive cerebrospinal fluid cul-
ture. Neonatal sepsis is defined as bacteraemia or menin-
gitis from day 0 to 59 of life. Malaria parasitemia was
concurrently present in some cases and these are analysed
as a separate class because malaria may have contributed
to mortality.
Control selection
Controls were selected at random from among a set of
healthy subjects who had originally been selected from
the community living near a case using the "spinning pen-
cil" technique and individually matched to cases on age,
sex and date of presentation to hospital in a case-control
study of both surviving and fatal cases of bacteraemia. For
ethical reasons, no controls were recruited among young
infants (age <60 days). Cases and controls were restricted
to the Mijikenda ethnic group indigenous to Coastal
Kenya. The subset of controls selected for the present
study was frequency-matched on age to cases in the
present study. In all multi-variable logistic regression
models age and administrative location of residence were
included. Age was specified in six strata (0–5 m, 6–11 m.
12–23 m, 24–35 m, 36–59 m, 60–151 m) each of which
contained between 13–19% of the observations. To con-
trol for ethnic diversity we stratified by administrative
authority, the best form of 'address' we could obtain,
yielding eight geographical locations each of which con-
tained between 4–26% of the data. These partitions allow
for some degree of geographic substructure and corre-
spond loosely with seven long established sub-groups of
the Mijikenda ethnic group, each of which has a different
language, and who tend to live in geographically defined
clusters.
Standardized Observed Homozygosity
SOH is the standardized observed homozygosity for an
individual genotyped for i loci. Nhom is the number of
homozygote genotypes in the individual concerned and
Hoi is the observed frequency of homozygotes the ith locus
scored in this individual, calculated across the full sample
set.
Population Attributable Risk Fractions
The PARFs were estimated as prev(OR-1)/(1+prev(OR-1)
for each marker in the final model of all invasive bacterial
disease deaths combined but, for simplicity, excluding the
interaction terms. The prevalence of homozygosity in the
population was estimated in the control population after
standardizing on age to the known age-distribution of the
population around the hospital. This was provided by the
Kilifi Demographic Surveillance Study, which has con-
ducted 2–3 household visits each year to enumerate the
population in an area accommodating 230,000 people
living closest to the hospital since 2000.
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